SLC5A2 and hydrops fetalis: Finally, despite being a contemporary HF patient population, adjustments to angiotensin receptor neprilysin inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors (iSLGT2) were not possible, first because the study was conducted before their co-payment by the Portuguese health system and the second because it was conducted before the approval of iSGLT2 for the treatment of HF.